P3 Health Partners (PIII) Common Equity (2019 - 2026)

P3 Health Partners (PIII) has 6 years of Common Equity data on file, last reported at -$155.2 million in Q4 2025.

• Quarterly Common Equity fell 304.42% year-over-year to -$155.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$155.2 million (down 304.42% YoY) and the FY2025 annual result came in at -$155.2 million, down 304.42% from the prior year.
• Common Equity slipped to -$155.2 million in Q4 2025, from -$18.7 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $263.0 million in Q1 2022 to a low of -$272.9 million in Q4 2021.
• A 5-year average of $13.2 million and a median of $53.9 million in 2025 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2024 — Common Equity surged 5559.81% — and 2025, when it sank 304.42%.
• Tracing PIII's Common Equity over 5 years: stood at -$272.9 million in 2021, then surged by 102.14% to $5.9 million in 2022, then jumped by 2327.91% to $142.1 million in 2023, then sank by 46.57% to $75.9 million in 2024, then sank by 304.42% to -$155.2 million in 2025.
• The last three Common Equity figures came in at -$155.2 million (Q4 2025), -$18.7 million (Q3 2025), and $44.5 million (Q2 2025), per Business Quant data.